Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICAP trial in COPD patients during severe air pollution in Beijing
ChiCTR-IPR-17010759Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide + formoterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Frequency of COPD exacerbations per year. Started Mar 2016; status: recruiting.
02
Drugs
budesonide + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-IPR-17010759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010759.